Fig. 1From: Using in vivo fluorescence lifetime imaging to detect HER2-positive tumorsFluorescence intensity (a.u.) and lifetime (sec) measured at the tumor and contralateral sites, 1Â h after injection of HER2-specific Affibody probeBack to article page